View in EDS HTML Full Text PDF Full Text

A Phase 1 Multiple-Dose, Open-Label, Pharmacokinetic Study of Nirmatrelvir/Ritonavir in Healthy Lactating Women.

Saved in:
Bibliographic Details
Title: A Phase 1 Multiple-Dose, Open-Label, Pharmacokinetic Study of Nirmatrelvir/Ritonavir in Healthy Lactating Women.
Authors: Gerhart J; Pfizer Research and Development, Pfizer Inc, Collegeville, Pennsylvania, USA., Cheruvu N; Pfizer Research and Development, Pfizer Inc, Collegeville, Pennsylvania, USA., Pelletier K; Pfizer Research and Development, Pfizer Inc, Groton, Connecticut, USA., Matschke K; Pfizer Research and Development, Pfizer Inc, Collegeville, Pennsylvania, USA., Shi H; Pfizer Research and Development, Pfizer Inc, Groton, Connecticut, USA., Mfopou JK; Pfizer Clinical Research Unit, Pfizer S.A./N.V., Brussels, Belgium., Hammond J; Pfizer Research and Development, Pfizer Inc, Collegeville, Pennsylvania, USA., Singh RSP; Pfizer Research and Development, Pfizer Inc, Cambridge, Massachusetts, USA.
Source: Clinical and translational science [Clin Transl Sci] 2026 May; Vol. 19 (5), pp. e70552.
Publication Type: Journal Article; Clinical Trial, Phase I
Journal Info: Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42012328
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Phase 1 Multiple-Dose, Open-Label, Pharmacokinetic Study of Nirmatrelvir/Ritonavir in Healthy Lactating Women.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gerhart+J%22">Gerhart J</searchLink>; Pfizer Research and Development, Pfizer Inc, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Cheruvu+N%22">Cheruvu N</searchLink>; Pfizer Research and Development, Pfizer Inc, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Pelletier+K%22">Pelletier K</searchLink>; Pfizer Research and Development, Pfizer Inc, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Matschke+K%22">Matschke K</searchLink>; Pfizer Research and Development, Pfizer Inc, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Shi+H%22">Shi H</searchLink>; Pfizer Research and Development, Pfizer Inc, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Mfopou+JK%22">Mfopou JK</searchLink>; Pfizer Clinical Research Unit, Pfizer S.A./N.V., Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Hammond+J%22">Hammond J</searchLink>; Pfizer Research and Development, Pfizer Inc, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Singh+RSP%22">Singh RSP</searchLink>; Pfizer Research and Development, Pfizer Inc, Cambridge, Massachusetts, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101474067%22">Clinical and translational science</searchLink> [Clin Transl Sci] 2026 May; Vol. 19 (5), pp. e70552.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22WileyBlackwell+Pub%22">WileyBlackwell Pub </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101474067 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1752-8062 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217528054%22">17528054 </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Sci <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42012328
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/cts.70552
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70552
    Titles:
      – TitleFull: A Phase 1 Multiple-Dose, Open-Label, Pharmacokinetic Study of Nirmatrelvir/Ritonavir in Healthy Lactating Women.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gerhart J
      – PersonEntity:
          Name:
            NameFull: Cheruvu N
      – PersonEntity:
          Name:
            NameFull: Pelletier K
      – PersonEntity:
          Name:
            NameFull: Matschke K
      – PersonEntity:
          Name:
            NameFull: Shi H
      – PersonEntity:
          Name:
            NameFull: Mfopou JK
      – PersonEntity:
          Name:
            NameFull: Hammond J
      – PersonEntity:
          Name:
            NameFull: Singh RSP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1752-8062
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Clinical and translational science
              Type: main
ResultId 1